CAS introduces CAS IP Finder for improved intellectual property search
The AI-enhanced solution deepens search capabilities and improves user experience COLUMBUS, Ohio,…
Phemex Launches Multi-Assets Mode to Enhance Trading Efficiency and Risk Management
APIA, Samoa, Sept. 12, 2025 /PRNewswire/ -- Phemex, the most efficient crypto…
IIHM Deepens Global Learning with 2025 Scot Malt Educational Tour
9 Students to Embark on Immersive Whisky Tour that Blends Tradition, Culture,…
IFQM Symposium 2025 to Drive India’s Journey Towards Global Quality Leadership
The Indian Foundation for Quality Management (IFQM), established by a consortium of…
Neo Space Group (NSG) to Acquire Display Interactive, Setting New Standards in In-Flight Connectivity for Airlines and Passengers
Upon closing, the acquisition will see Display Interactive become part of NSG.PIF's…
LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry
Social Leverage backs LEA’s mission to eliminate manual document work and quickly…
Corviable Launches Bold Global Revamp — Unveils Next-Gen Website, Portal, and Real-Time Business Investment Capabilities
DETROIT, Sept. 8, 2025 /PRNewswire/ -- Corviable, one of the fastest-growing leaders in…
Six Industry-Leading Breakthroughs! GAC Officially Launches ADiMOTION, Defining China’s Top Range-Extending Technology
MUNICH, Sept. 6, 2025 /PRNewswire/ -- Recently, GAC officially introduced its all-new extended-range…
Yutong Bus Link+ Empowers Fleets with Intelligent Management and Higher Operational Efficiency
ZHENGZHOU, China, Sept. 5, 2025 /PRNewswire/ -- Yutong Bus ("Yutong", SHA: 600066), a…
![U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease](https://i3.wp.com/mms.businesswire.com/media/20250905840795/en/1247790/22/Takeda_Red_Logo_2021.jpg?w=420&resize=420,280&ssl=1 "U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease"){kind=logo}
U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce…
